| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 667449 | Null | 0.0112425217758227 | 0.14519267 |
| NSC 674278 | Null | 0.0112425217758227 | -0.40686562 |
| NSC 675251 | Null | 0.0112425217758227 | 0.088043842 |
| NSC 680420 | Null | 0.0112425217758227 | 0.039124821 |
| NSC 705871 | 1H-Indole, 5-bromo-3-[2-(2-pyridinyl)-4-thiazolyl]- | 0.0112425217758227 | 0.23374298 |
| NSC 726718 | 3-(Benzothiazol-6-ylamino)-7-chloro-8-methyl-1,1,-dioxo-4H-1 ,5,2-benzodithiazepin-4-ylideneacetic acid | 0.0112425217758227 | 0.38908354 |
| NSC 727985 | NSC 708781 incorporated in micelles, 0.55% (w/w) of drug | 0.0112425217758227 | 0.21324248 |
| NSC 728512 | 1-Allyl-2-[4-chloro-5-(4-chlorophenylcarbamoyl)-2-methylthio benzenesulfonyl]-3-(5-nitro-2-furfulienimino)guanidine | 0.0112425217758227 | 0.45323674 |
| NSC 730460 | 16-[4-{(3-Imidazol-1-yl)propoxy}-3-methoxybenzylidene]-3b-py rrolidino-5-androsten-17b-YL acetate | 0.0112425217758227 | 0.43347912 |
| NSC 744231 | Null | 0.0112425217758227 | 0.22557245 |